The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration
Description
The study will assess the safety and efficacy of Everolimus (RAD001) alone or in combination with Lucentis in patients with neo-vascular age related macular degeneration (AMD)